Who are Unicycive Therapeutics, Inc.'s main suppliers?

Unicycive Therapeutics, Inc. (UNCY) key suppliers include: SHILPA, SPECTRUM-PHARMACEUTICALS-INC. View the full supplier network at chainsifter.com/chain/UNCY.

What sector is Unicycive Therapeutics, Inc. in?

Unicycive Therapeutics, Inc. (UNCY) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

Unicycive Therapeutics, Inc. (UNCY): 5 Verified Supply Chain Relationships

2Suppliers

0Customers

3Debt Items

0Related Chains

Source-Backed Evidence Depth

Unicycive Therapeutics, Inc. (UNCY) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

6Total relationships

3Distinct source URLs

6High confidence

0.907Average confidence

2026-10-28Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Unicycive Therapeutics, Inc. Suppliers

Ticker	Name	Confidence	Evidence
SHILPA	SHILPA	92%	On June 29, 2023 and October 26, 2023, the Company entered into services agreements with Shilpa related to NDA filing support for oxylanthanum carbonate.
SPECTRUM-PHARMACEUTICALS-INC	SPECTRUM-PHARMACEUTICALS-INC	92%	Pursuant to the Spectrum Agreement, in consideration for the Compounds, we issued 313,663 shares of common stock to Spectrum.

Unicycive Therapeutics, Inc. Customers

No clients on recordUnicycive Therapeutics, Inc. does not appear to disclose named customer relationships in its verified regulatory filings. Many companies do not publicly name customers in regulatory disclosures.

Unicycive Therapeutics, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
UNCY-DEBT-13219	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2021-12-31.
UNCY-DEBT-13218	Warrants outstanding: 6	90%	xbrl warrant detail from xbrl 2025-12-31.
UNCY-DEBT	Debt stack $815,000	90%	Market cache reports total debt of $815,000.

Unicycive Therapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Unicycive Therapeutics, Inc..

Unicycive Therapeutics, Inc. Ownership

Holder	Name	Confidence	Evidence
UNCY-OWNER-VIVO-CAPITAL-LLC	Vivo Capital, LLC	90%	13F overlay lists Vivo Capital, LLC as top holder; 51 tracked holders.

Unicycive Therapeutics, Inc. Extended Supply Chain Network

No secondary connectionsNo correlated companies found through shared supply chain relationships.

Unicycive Therapeutics, Inc. Supply Chain